Developmental Neuroscience

Original Paper

Neonatal Benzo[a]pyrene Exposure Induces Oxidative Stress and DNA Damage Causing Neurobehavioural Changes during the Early Adolescence Period in Rats

Patel B. · Das S.K. · Patri M.

Author affiliations

Neurobiology Laboratory, Department of Zoology, School of Life Sciences, Ravenshaw University, Cuttack, India

Related Articles for ""

Dev Neurosci 2016;38:150-162

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 9.00 *
EUR 8.00 *
USD 9.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 11, 2015
Accepted: April 18, 2016
Published online: June 07, 2016
Issue release date: June 2016

Number of Print Pages: 13
Number of Figures: 5
Number of Tables: 0

ISSN: 0378-5866 (Print)
eISSN: 1421-9859 (Online)

For additional information: https://www.karger.com/DNE

Abstract

Humans are exposed to polycyclic aromatic hydrocarbons (PAHs) by ingestion of contaminated food and water. Prenatal exposure to benzo[a]pyrene (B[a]P) like PAHs through the placental barrier and neonatal exposure by breast milk and the environment may affect early brain development. In the present study, single intracisternal administration of B[a]P (0.2 and 2.0 µg/kg body weight) to male Wistar rat pups at postnatal day 5 (PND5) was carried out to study its specific effect on neonatal brain development and its consequences at PND30. B[a]P administration showed a significant increase in exploratory and anxiolytic-like behaviour with elevated hippocampal lipid peroxidation and protein oxidation at PND30. Further, DNA damage was estimated in vitro (Neuro2a and C6 cell lines) by the comet assay, and oxidative DNA damage of hippocampal sections was measured in vivo following exposure to B[a]P. DNA strand breaks (single and double) significantly increased due to B[a]P at PND30 in hippocampal neurons and increased the nuclear tail moment in Neuro2a cells. Hippocampal 8-oxo-2′-deoxyguanosine production was significantly elevated showing expression of more TUNEL-positive cells in both doses of B[a]P. Histological studies also revealed a significant reduction in mean area and perimeter of hippocampal neurons in rats treated with B[a]P 2.0 μg/kg, when compared to naïve and control rats. B[a]P significantly increased anxiolytic-like behaviour and oxidative DNA damage in the hippocampus causing apoptosis that may lead to neurodegeneration in adolescence. The findings of the present study address the potential role of B[a]P in inducing oxidative stress-mediated neurodegeneration in the hippocampus through oxidative DNA damage in the early adolescence period of rats.

© 2016 S. Karger AG, Basel




Related Articles:


References

  1. Li QQ, Loganath A, Chong YS, Tan J, Obbard JP: Persistent organic pollutants and adverse health effects in humans. J Toxicol Environ Health A 2006;69:1987-2005.
  2. Patri M, Padmini M, Babu PP: Polycyclic aromatic hydrocarbons in air and their neurotoxic potency in association with oxidative stress: a brief perspective. Ann Neurosci 2009;16:1.
    External Resources
  3. Saunders CR, Das SK, Ramesh A, Shockley DC, Mukherjee S: Benzo(a)pyrene-induced acute neurotoxicity in the F-344 rat: role of oxidative stress. J Appl Toxicol 2006;26:427-438.
  4. Cheng SQ, Xia YY, He JL, Liu XQ, Chen XM, Ding YB, Wang YX, Peng B, Tu BJ: Neurotoxic effect of subacute benzo(a)pyrene exposure on gene and protein expression in Sprague-Dawley rats. Environ Toxicol Pharmacol 2013;36:648-658.
  5. Xu G, McMahan CA, Walter CA: Early-life exposure to benzo[a]pyrene increases mutant frequency in spermatogenic cells in adulthood. PLoS One 2014;9:e87439.
  6. Perera FP, Tang D, Rauh V, Lester K, Tsai WY, Tu YH, Weiss L, Hoepner L, King J, Del Priore G, Lederman SA: Relationships among polycyclic aromatic hydrocarbon-DNA adducts, proximity to the World Trade Center, and effects on fetal growth. Environ Health Perspect 2005;113:1062-1067.
  7. Hack M, Breslau N, Weissman B, Aram D, Klein N, Borawski E: Effect of very low birth weight and subnormal head size on cognitive abilities at school age. New Engl J Med 1991;325:231-237.
  8. Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D: Effects of transplacental exposure to environmental pollutants on birth outcomes in a multi-ethnic population. Environ Health Perspect 2003;111:201-205.
  9. Perera FP, Rauh V, Whyatt RM, Tang D, Tsai WY, Bernert JT, Tu YH, Andrews H, Barr DB, Camann DE, Diaz D, Dietrich J, Reyes A, Kinney PL: A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology 2005;26:573-587.
  10. Davila DR, Romero DL, Burchiel SW: Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by alpha-naphthoflavone. Toxicol Appl Pharmacol 1996;139:333-341.
  11. Weiss B: Vulnerability of children and the developing brain to neurotoxic hazards. Environ Health Perspect 2000;108:375-381.
  12. Perera F, Tang D, Whyatt R, Lederman SA, Jedrychowski W: DNA damage from polycyclic aromatic hydrocarbons measured by benzo[a]pyrene-DNA adducts in mothers and newborns from Northern Manhattan, the World Trade Center Area, Poland, and China. Cancer Epidemiol Biomarkers Prev 2005;14:709-714.
  13. Patri M, Singh A, Mallick BN: Protective role of noradrenaline in benzo[a]pyrene-induced learning impairment in developing rat. J Neurosci Res 2013;91:1450-1462.
  14. Das M, Mukhtar H, Seth P: Distribution of benzo(a)pyrene in discrete regions of the rat brain. Bull Environ Contam Toxicol 1985;35:500-504.
  15. Mitchell CE: Distribution and retention of benzo(A)pyrene in rats after inhalation. Toxicol Lett 1982;11:35-42.
  16. Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM: Metabolism, bioavailability, and toxicokinetics of benzo(a)pyrene in F-344 rats following oral administration. Exp Toxicol Pathol 2001;53:275-290.
  17. Kim KB, Lee BM: Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo(a)pyrene. Cancer Lett 1997;113:205-212.
  18. Thakker DR, Yagi H, Akagi H, Koreeda M, Lu AH, Levin W, Wood AW, Conney AH, Jerina DM: Metabolism of benzo[a]pyrene. VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides. Chem Biol Interact 1977;16:281-300.
  19. Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM, Conney AH: Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. Cancer Res 1979;39:67-71.
    External Resources
  20. Phillips DH: Fifty years of benzo(a)pyrene. Nature 1983;303:468-472.
  21. Cavalieri EL, Rogan EG: The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation. Pharmacol Ther 1992;55:183-199.
  22. Cavalieri EL, Rogan EG: Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 1995;25:677-688.
  23. Pappas BA, Gallivan JV, Dugas T, Saari M, Ings R: Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction. Psychopharmacology (Berl) 1980;70:41-46.
  24. Shaywitz BA, Teicher MH, Cohen DJ, Anderson GM, Young JG, Levitt P: Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup. Psychopharmacology (Berl) 1984;82:73-77.
  25. Ishido M, Masuo Y, Kunimoto M, Oka S, Morita M: Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J Neurosci Res 2004;76:423-433.
  26. Markel AL, Galaktionov YuK, Efimov VM: Factor analysis of rat behavior in an open field test. Neurosci Behav Physiol 1989;19:279-286.
  27. Das SK, Baitharu I, Barhwal K, Hota SK, Singh SB: Early mood behavioral changes following exposure to monotonous environment during isolation stress is associated with altered hippocampal synaptic plasticity in male rats. Neurosci Lett 2016;612:231-237.
  28. Herrero AI, Sandi C, Venero C: Individual differences in anxiety trait are related to spatial learning abilities and hippocampal expression of mineralocorticoid receptors. Neurobiol Learn Mem 2006;86:150-159.
  29. Das SK, Barhwal K, Hota SK, Thakur MK, Srivastava RB: Disrupting monotony during social isolation stress prevents early development of anxiety and depression like traits in male rats. BMC Neurosci 2015;16:2.
  30. Dousset JC, Trouilh M, Foglietti MJ: Plasma malonaldehyde levels during myocardial infarction. Clin Chim Acta 1983;129:319-322.
  31. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-478.
  32. Rani BU, Singh NI, Ray A, Rao KS: Procedure for isolation of neuron- and astrocyte-enriched fractions from chick brain of different ages. J Neurosci Res 1983;10:101-105.
  33. Singh NP, McCoy MT, Tice RR, Schneider EL: A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-191.
  34. Swain U, Subba Rao K: Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging. Mech Ageing Dev 2011;132:374-381.
  35. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
  36. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 1998.
  37. Cheng Y, Zhang Y, Song H, Feng J: Intercellular adhesion molecule-1 expression in the hippocampal CA1 region of hyperlipidemic rats with chronic cerebral ischemia. Neural Regen Res 2012;7:1312-1317.
  38. Majumdar S, Mallick BN: Increased levels of tyrosine hydroxylase and glutamic acid decarboxylase in locus coeruleus neurons after rapid eye movement sleep deprivation in rats. Neurosci Lett 2003;338:193-196.
  39. Chen C, Tang Y, Jiang X, Qi Y, Cheng S, Qiu C, Peng B, Tu B: Early postnatal benzo(a)pyrene exposure in Sprague-Dawley rats causes persistent neurobehavioral impairments that emerge postnatally and continue into adolescence and adulthood. Toxicol Sci 2012;125:248-261.
  40. UNEP-United Nations Environmental program. Urban air pollution UNEP/GEMS Environment Library No 4. 1991.
  41. Miller KP, Ramos KS: Impact of cellular metabolism on the biological effects of benzo(a)pyrene and related hydrocarbons. Drug Metab Rev 2001;33:1-35.
  42. McCallister MM, Maguire M, Ramesh A, Aimin Q, Liu S, Khoshbouei H, Aschner M, Ebner FF, Hood DB: Prenatal exposure to benzo(a)pyrene impairs later-life cortical neuronal function. Neurotoxicology 2008;29:846-854.
  43. Grova N, Valley A, Turner JD, Morel A, Muller CP, Schroeder H: Modulation of behavior and NMDA-R1 gene mRNA expression in adult female mice after sub-acute administration of benzo(a)pyrene. Neurotoxicology 2007;28:630-636.
  44. Bouayed J, Desor F, Rammal H, Kiemer AK, Tybl E, Schroeder H, Rychen G, Soulimani R: Effects of lactational exposure to benzo[alpha]pyrene (B[alpha]P) on postnatal neurodevelopment, neuronal receptor gene expression and behaviour in mice. Toxicology 2009;259:97-106.
  45. Zanieri L, Galvan P, Checchini L, Cincinelli A, Lepri L, Donzelli GP, Del Bubba M: Polycyclic aromatic hydrocarbons (PAHs) in human milk from Italian women: influence of cigarette smoking and residential area. Chemosphere 2007;67:1265-1274.
  46. Patel B, Das SK, Das S, Das L, Patri M: Neonatal exposure to benzo[a]pyrene induces oxidative stress causing altered hippocampal cytomorphometry and behavior during early adolescence period of male Wistar rats. Int J Dev Neurosci 2016;50:7-15.
  47. Das SK, Patel B, Patri M: Neurotoxic effect of benzo[a]pyrene and its possible association with 6-hydroxydopamine induced neurobehavioral changes during early adolescence period in rats. J Toxicol 2016;2016:8606410.
  48. Chengzhi C, Yan T, Shuqun C, Xuejun J, Youbin Q, Yinyin X, Qian T, Baijie T: New candidate proteins for benzo(a)pyrene-induced spatial learning and memory deficits. J Toxicol Sci 2011;36:163-171.
  49. Briedé JJ, Godschalk RW, Emans MT, De Kok TM, Van Agen E, Van Maanen J, Van Schooten FJ, Kleinjans JC: In vitro and in vivo studies on oxygen free radical and DNA adduct formation in rat lung and liver during benzo[a]pyrene metabolism. Free Radic Res 2004;38:995-1002.
  50. Henkler F, Stolpmann K, Luch A: Exposure to polycyclic aromatic hydrocarbons: bulky DNA adducts and cellular responses. EXS 2012;101:107-131.
  51. Garry S, Nesslany F, Aliouat E, Haguenoer JM, Marzin D: Assessment of genotoxic effect of benzo[a]pyrene in endotracheally treated rat using the comet assay. Mutat Res 2003;534:33-43.
  52. Mourón SA, Grillo CA, Dulout FN, Golijow CD: Genotoxic effects of benzo[a]pyrene and dibenzo[a [,]l]pyrene in a human lung cell line. Int J Toxicol 2006;25:49-55.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 11, 2015
Accepted: April 18, 2016
Published online: June 07, 2016
Issue release date: June 2016

Number of Print Pages: 13
Number of Figures: 5
Number of Tables: 0

ISSN: 0378-5866 (Print)
eISSN: 1421-9859 (Online)

For additional information: https://www.karger.com/DNE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP